-The Indian Express It was once thought impossible, but a 35-year-fight has won India its biggest public health success story. Raxaul: It was once thought impossible, but two million footsoldiers and a 35-year-fight have won India its biggest public health success story. Pritha Chatterjee & Santosh Singh on how the battle was won and the biggest challenges ahead. It's one of the busiest spots along the porous India-Nepal border. At about 1.30 pm...
More »SEARCH RESULT
Indian patent rulings may face legal heat internationally -Soma Das
-The Economic Times The recent patent rulings in India may get frequently challenged in international courts if the government yields to the European Union's demand of including matters related to intellectual property in the investors-state dispute mechanism in their proposed trade pact, health activist groups have warned. An investor-state dispute resolution mechanism typically allows foreign investors to sue countries for compensation if national laws, policies, court rulings of the country infringe upon...
More »Novartis patent case: Glivec developer Brian Druker hails SC ruling- Chidanand Rajghatta
-The Economic Times WASHINGTON: Big Pharma found little support from the small guy on the street as the Indian Supreme Court's decision to reject patent claims of the drug maker Novartis for its celebrated cancer medicine Glivec reverberated across the world. The pharma lobby railed against the decision but the overwhelming sentiment, from physicians to politicians, from academia to media, particularly in a country groaning from the high cost of health care,...
More »European Union-India FTA may hit generic medical industry-Rema Nagarajan
-The Times of India The free trade agreement that European Union is pushing India to sign could put an end to India's status as the pharmacy of the developing providing affordable medicines, especially HIV drugs to countries like Brazil, Thailand, South Africa, Zimbabwe and several others. The negotiations with EU are on at a feverish pace this week in Brussels even before the parliamentary standing committee looking into the free trade...
More »Western warnings-R Ramachandran
India is coming under increasing pressure from the U.S. and the European Union for the strict patentability criteria it applies for medicines. AS was only to be expected, the two landmark decisions made by the Indian patent office in recent times concerning pharmaceutical patent cases have not gone down well with the multinational drug industry. First, there was the rejection in 2006 of the patent application by the Swiss multinational...
More »